EUVIMEDEUVIMED entdecken
Crossref

Switching frail older people with AF from a vitamin K antagonist to a DOAC

Drug and Therapeutics Bulletin · 2024

DOI: 10.1136/dtb.2024.000037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Therapeutics Bulletin, 2024. Hauptthemen laut MEDLINE: Atrial Fibrillation, Vitamin K, Frail Elderly. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomised controlled trial

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationVitamin KFrail ElderlyHumansAgedFactor Xa InhibitorsAnticoagulantsAged, 80 and overDrug Substitution

Stichwörter der Autor:innen

Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and Evaluation

Substanzen

Vitamin KFactor Xa InhibitorsAnticoagulants

Zitieren

APA

(2024). Switching frail older people with AF from a vitamin K antagonist to a DOAC. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2024.000037

Vancouver

Switching frail older people with AF from a vitamin K antagonist to a DOAC. Drug and Therapeutics Bulletin. 2024. doi:10.1136/dtb.2024.000037

BibTeX
@article{euvimed2024,
  title = {Switching frail older people with AF from a vitamin K antagonist to a DOAC},
  journal = {Drug and Therapeutics Bulletin},
  year = {2024},
  doi = {10.1136/dtb.2024.000037}
}
Kostenlos starten →